AR and prostate neoplasm: Collecting CTCs from blood has also been termed “liquid tumor biopsy.” Miyamoto and colleagues found considerable heterogeneity, including expression of androgen receptor (AR) gene mutations and splicing variants in the circulating prostate tumor cells by RNA sequencing [37].